1. NITINKUMAR DALSUKHRAY PAREKH-040437 NITINKUMAR DALSUKHRAY PAREKH-040437 CFO-HEALTHCARE CFO-HEALTHCARE CFO-CADILA HEALTHCARE LIMITED

2. Turnover (Sales) of the Company in Rupees: Consolidated sales of Rs. 5090 crores for the year ended 31 st March,2012 Turnover (Sales) of the Company in Rupees: Consolidated sales of Rs. 5090 crores for the year ended 31 st March,2012 Net worth of the Company: Rs. 2483 crores as on 31 st March, 2012 Net worth of the Company: Rs. 2483 crores as on 31 st March, 2012 Market Capitalization of the Organization: Rs.18200 crores based on market price of Rs.889 on 5 th November, 2012 Market Capitalization of the Organization: Rs.18200 crores based on market price of Rs.889 on 5 th November, 2012 Details of individual companies is available in annual report Details of individual companies is available in annual report Note: Please give details of the company where the person is located. For CA Business Achiever or CFO where person is handling multiple companies within a group, please give composite details of all companies under the domain of nominee. Details of Individual companies may be given separately. The applicants of CA Professional Achiever should give details only of the company where they are working.

3. KEY ROLE IN THE ORGANIZATION I am a member of the Zydus Management Council which is the top management body. I am on the Board of Directors of group companies like Biochem Pharmaceutical and Liva Healthcare. I am a member of the Zydus Management Council which is the top management body. I am on the Board of Directors of group companies like Biochem Pharmaceutical and Liva Healthcare. My role and responsibilities include functions like Accounts, Banking, Budgeting, Costing, Corporate Governance, Direct & Indirect Taxes, Forex Management, MIS, M&A, Management Audit, Risk Management, Secretarial maters and Treasury My role and responsibilities include functions like Accounts, Banking, Budgeting, Costing, Corporate Governance, Direct & Indirect Taxes, Forex Management, MIS, M&A, Management Audit, Risk Management, Secretarial maters and Treasury The group has currently embarked upon the journey of achieving its vision of USD 3 billion turnover by 2015. I am entrusted with the responsibility of Collaboration which is important pillar of growth. The group has currently embarked upon the journey of achieving its vision of USD 3 billion turnover by 2015. I am entrusted with the responsibility of Collaboration which is important pillar of growth. The group is implementing a project called PRISM-II with annual cost savings target of Rs.188 crores with help of McKinsey. I am handling the responsibility of institutionalization of this cost saving process and creating cost consciousness as a DNA of group. The group is implementing a project called PRISM-II with annual cost savings target of Rs.188 crores with help of McKinsey. I am handling the responsibility of institutionalization of this cost saving process and creating cost consciousness as a DNA of group. I directly report to Chairman and Managing Director of the company, Shri Pankaj Patel I directly report to Chairman and Managing Director of the company, Shri Pankaj Patel

4. MAJOR ACHIEVEMENTS During the accounting year 2011-12, three acquisition deals were executed successfully. The first was acquisition of 100% share capital of Mumbai based Biochem Pharmaceutical Industries Ltd. Second was asset acquisition of US based Nesher Pharma and third was acquisition of 100% share capital of Germany based Bremer Pharma. These three deals in aggregate amount to Rs. 900 crores. The role was as a member of the team which consisted of Business Head, Finance Head (me) and Legal Head. My role included due diligence of the target entities, negotiation of commercial terms, structuring of the deal, negotiation of the legal documents like share purchase agreement, asset purchase agreement, escrow agreement etc., presentation of acquisition rationale to the Board of Directors of Cadila, innovative and cost effective funding of the deal and ultimate closure including intimation to statutory authorities and clearances. During the accounting year 2011-12, three acquisition deals were executed successfully. The first was acquisition of 100% share capital of Mumbai based Biochem Pharmaceutical Industries Ltd. Second was asset acquisition of US based Nesher Pharma and third was acquisition of 100% share capital of Germany based Bremer Pharma. These three deals in aggregate amount to Rs. 900 crores. The role was as a member of the team which consisted of Business Head, Finance Head (me) and Legal Head. My role included due diligence of the target entities, negotiation of commercial terms, structuring of the deal, negotiation of the legal documents like share purchase agreement, asset purchase agreement, escrow agreement etc., presentation of acquisition rationale to the Board of Directors of Cadila, innovative and cost effective funding of the deal and ultimate closure including intimation to statutory authorities and clearances. For financial leverage, I have convinced the management to adopt and also publicly announce the debt equity ratio guideline. Accordingly, we have declared that our consolidated net debt equity ratio would be within the band of 0.5: 1 to maximum 1:1. Considering my unique and important contribution in risk management category, CFO Institute has given me CFO100 roll of honour for 2012. The annual report of Cadila for 2011-12 contains this information with my photograph. Finance department has created web based portal for legal compliances. I am responsible for corporate governance aspects and have created elaborate systems and processes. Recently we carried out study through the help of one Big 4 firm for best practices followed by Pharma and other industries for foreign exchange management and thus decided to go for put option for managing the forex risk.

5. MAJOR ACHIEVEMENTS I also periodically meet various investors and participate in Investors meet. Recently in September, 2012 I had one to one meetings with various international investors in Hong Kong and Singapore. Zydus Cadila has been currently working on the cost savings project called PRISM-II. This project is targeted to have annual cost savings of Rs. 188 crores to be achieved by March-2014. I am sponsor of this project and also in charge of institutionalization of this process. All M&A deals involve substantial legal documentation work. Though we have our in house legal department, I am the main person responsible for all commercial terms and very actively involved in negotiation and finalisation of legal documents. Apart from this I am responsible for compliance of all corporate laws and provide a detailed compliance report and a booklet of compliance under clause 49 of listing requirements. I possess other qualifications which supplement my professional capabilities to discharge my role. I have done MBA from Indian Institute of Management, Ahmedabad and also possess qualifications like CFA and LL.B. I have attended leadership training programs conducted by internationally acclaimed personalities like Prof. Ram Charan and Prof. Steven Sonsino. I am very good orator and give lectures at various forums on topics ranging from educational, social to religious segments. My interviews have been taken by CNBC and I am often interviewed and quoted by newspapers like Times of India, Economic Times etc.. I have given lectures after Union Budget on budget impact. Note- Please specify exact role whether the achievement is as a member of team or team leader or in any other capacity.